| Primary |
| Drug Use For Unknown Indication |
87.5% |
| Insomnia |
12.5% |
|
|
| Secondary |
| Upper Respiratory Tract Inflammation |
17.6% |
| Hypertension |
11.8% |
| Drug Use For Unknown Indication |
7.8% |
| Nasopharyngitis |
7.8% |
| Constipation |
5.4% |
| Prostate Cancer |
5.4% |
| Diabetes Mellitus |
4.7% |
| Pneumonia |
4.7% |
| Chronic Obstructive Pulmonary Disease |
4.4% |
| Product Used For Unknown Indication |
4.1% |
| Pneumonia Aspiration |
3.7% |
| Bronchitis |
3.0% |
| Back Pain |
2.7% |
| Hyperlipidaemia |
2.7% |
| Insomnia |
2.7% |
| Upper Respiratory Tract Infection |
2.7% |
| Gastritis |
2.4% |
| Nasal Septum Deviation |
2.4% |
| Anxiety Disorder |
2.0% |
| Gastric Ulcer |
2.0% |
|
| Interstitial Lung Disease |
16.3% |
| Stevens-johnson Syndrome |
10.2% |
| Hypoglycaemia |
6.1% |
| Sick Sinus Syndrome |
6.1% |
| Stomatitis |
6.1% |
| Upper Respiratory Tract Inflammation |
6.1% |
| Volvulus |
6.1% |
| Atrioventricular Block Complete |
4.1% |
| Blood Creatine Phosphokinase Increased |
4.1% |
| Jaundice |
4.1% |
| Lung Infiltration |
4.1% |
| Renal Failure Acute |
4.1% |
| Restlessness |
4.1% |
| Toxic Skin Eruption |
4.1% |
| Uveitis |
4.1% |
| Blood Creatinine Increased |
2.0% |
| Drug Eruption |
2.0% |
| Eosinophilic Pneumonia |
2.0% |
| Haemoptysis |
2.0% |
| Hyperkalaemia |
2.0% |
|
| Concomitant |
| Asthma |
28.5% |
| Product Used For Unknown Indication |
22.9% |
| Drug Use For Unknown Indication |
10.1% |
| Bronchitis |
7.1% |
| Prophylaxis |
4.7% |
| Pneumonia |
4.2% |
| Hypertension |
3.3% |
| Gastritis |
2.4% |
| Rheumatoid Arthritis |
2.0% |
| Chronic Myeloid Leukaemia |
2.0% |
| Cough |
2.0% |
| Myelodysplastic Syndrome |
1.7% |
| Pyrexia |
1.5% |
| Atrial Fibrillation |
1.3% |
| Colitis Ulcerative |
1.1% |
| Depression |
1.1% |
| Constipation |
1.1% |
| Upper Respiratory Tract Inflammation |
1.1% |
| Dementia Alzheimer's Type |
1.0% |
| Diabetes Mellitus |
1.0% |
|
| White Blood Cell Count Decreased |
12.6% |
| Pneumonia |
11.5% |
| Interstitial Lung Disease |
9.2% |
| Rash |
9.2% |
| Upper Respiratory Tract Inflammation |
6.9% |
| Renal Impairment |
5.7% |
| Thirst |
5.7% |
| Lobar Pneumonia |
4.6% |
| Pyrexia |
4.6% |
| Sepsis |
4.6% |
| Thrombocytopenia |
4.6% |
| Blood Albumin Decreased |
2.3% |
| Cerebral Infarction |
2.3% |
| Death |
2.3% |
| Haematochezia |
2.3% |
| Haematuria |
2.3% |
| Ileus |
2.3% |
| Lung Disorder |
2.3% |
| Lymphocyte Count Decreased |
2.3% |
| Pneumocystis Jiroveci Pneumonia |
2.3% |
|
